Allianz Asset Management Gmb H Iveric Bio, Inc. Transaction History

Allianz Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$26.24 - $39.63 $663,216 - $1 Million	25,275 Added 50.45%	75,375 $2.97 Million
Q1 2023 May 11, 2023	SELL	$18.67 - $24.56 $224,040 - $294,720	-12,000 Reduced 19.32%	50,100 $1.22 Million
Q4 2022 Feb 13, 2023	BUY	$17.24 - $23.95 $239,635 - $332,905	13,900 Added 28.84%	62,100 $1.33 Million
Q3 2022 Nov 08, 2022	SELL	$9.4 - $18.59 $2.33 Million - $4.62 Million	-248,349 Reduced 83.75%	48,200 $865,000
Q2 2022 Aug 12, 2022	SELL	$9.12 - $18.9 $726,718 - $1.51 Million	-79,684 Reduced 21.18%	296,549 $2.85 Million
Q1 2022 May 13, 2022	BUY	$12.15 - $16.83 $2.36 Million - $3.27 Million	194,432 Added 106.95%	376,233 $6.33 Million
Q4 2021 Feb 11, 2022	BUY	$13.83 - $18.78 $1.2 Million - $1.63 Million	86,751 Added 91.27%	181,801 $3.03 Million
Q3 2021 Nov 10, 2021	BUY	$7.07 - $17.5 $672,003 - $1.66 Million	95,050 New	95,050 $1.54 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.